Drug intelligence / Profile preview

Niargim

Development stage
Unknown
Lead developer
AVN Ayurveda Formulations
Administration
Oral
01

Overview

Niargim is an Ayurvedic polyherbal formulation developed by AVN Ayurveda Formulations Pvt. Ltd. for the prophylaxis and management of migraine, tension headaches, and headaches associated with depression. The formulation integrates traditional Ayurvedic components, including Varanadi Kashayam and Drakshadi Kashayam, with specific herbs such as Brahmi (Bacopa monnieri) and Rasna (Pluchea lanceolata). Its therapeutic effect is attributed to a multi-pronged mechanism: the suppression of prostaglandin synthesis (via Varanadi Kashayam and Rasna) to provide anti-inflammatory and analgesic relief, and the modulation of 5-hydroxytryptamine (serotonin) receptors (via Drakshadi Kashayam and Brahmi) to regulate local vasodilation and offer neuroprotective benefits. It is administered orally as 850 mg tablets and is marketed as a safe alternative to conventional migraine therapies.

Brand names
NiargimNiargim Tablets
Other names
Niargim-AVN Ayurveda Formulations-herbal formulation
02

Targets

HTR3A (5-hydroxytryptamine receptor 3A)

Beyond the preview

Go deeper on Niargim.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Niargim.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call